Advertisement

Medetomidine and dexmedetomidine: a review of cardiovascular effects and antinociceptive properties in the dog

      Abstract

      Alpha2-adrenoreceptor agonists (α2-agonists) are commonly used in small animal anaesthesia for their potent sedative and analgesic properties, although concerns about their cardiovascular effects have prevented their full adoption into veterinary practice. Research into alpha2 adrenoreceptor agonists and their clinical use is extensive, therefore this review focuses on the use of dexmedetomidine and medetomidine in dogs. Emphasis is given to the cardiovascular effects and antinociceptive action of these agents.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aantaa R
        • Kallio A
        • Virtanen R
        Dexmedetomidine, a novel alpha2-adrenergic agonist. A review of its pharmacodynamic characteristics.
        Drugs Future. 1989; 18: 49-91
        • Aghajanian G
        • VanderMaelen C
        Alpha2 adrenoreceptor mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo.
        Science. 1982; 215: 1394-1396
        • Alibhai H
        • Clarke K
        • Lee Y
        • et al.
        Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs.
        Vet Rec. 1996; 138: 11-13
        • Ansah O
        • Raekallio M
        • Vainio O
        Comparison of three doses of dexmedetomidine with medetomidine in cats following intramuscular administration.
        J Vet Pharmacol Ther. 1998; 21: 380-387
        • Ansah O
        • Raekallio M
        • Vainio O
        Correlation between serum concentrations following intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects.
        J Vet Pharmacol Ther. 2000; 23: 1-8
        • Arner S
        • Meyerson B
        Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.
        Pain. 1988; 33: 11-23
        • Badoer E
        • Head G
        • Korner P
        Effects of intracisternal and intravenous alpha-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits.
        J Cardiovasc Pharmacol. 1983; 5: 760-767
        • Barnhart M
        • Hubbell J
        • Muir W
        Evaluation of the analgesic properties of acepromazine maleate, oxymorphone, medetomidine and a combination of acepromazine–oxymorphone.
        Vet Anaesth Analg. 2000; 27: 89-96
        • Bartram D
        • Diamond M
        • Tute A
        • et al.
        Use of medetomidine and butorphanol for sedation in dogs.
        J Small Anim Pract. 1994; 35: 495-498
        • Belcher G
        • Ryall R
        • Schaffner R
        The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurons in the cat.
        Brain Res. 1978; 151: 307-321
        • Bloor B
        • Frankland M
        • Alper G
        • et al.
        Haemodynamic and sedative effects of dexmedetomidine in dog.
        J Pharmacol Exp Ther. 1992; 263: 690-697
        • Brodbelt D
        • Wood J
        • Young L
        • et al.
        Perioperative anaesthetic complications in cats and dogs.
        Vet Rec. 2002; 150: 616
        • Bylund D
        Heterogeneity of alpha-2 adrenergic receptors.
        Pharmacol Biochem Behav. 1985; 22: 835-843
        • Carlton S
        • Honda CN
        • Willcockson WS
        • et al.
        Descending adrenergic input to the primate spinal cord and its possible role in modulation of spinothalamic tract cells.
        Brain Res. 1991; 591: 77-90
        • Chilian W
        • Ackell P
        Transmural differences in sympathetic coronary constriction during exercise in the presence of coronary stenosis.
        Circ Res. 1988; 62: 216-225
        • Clarke K
        • Hall L
        A survey of anaesthesia in small animal practice: AVA/BSAVA report.
        Vet Anaesth Analg. 1990; 17: 4-10
        • Corr P
        • Yamada K
        • Witkowski F
        Mechanisms controlling cardiac autonomic function and their relation to arrhythmogenesis.
        in: Fozzard H Haber E Jennings R Katz A Morgan H The Heart and Cardiovascular System. Raven, New York1986: 1343-1403
        • Coughlan M
        • Lee JG
        • Bosnjak ZJ
        • et al.
        Direct coronary and cerebral vascular responses to dexmedetomidine.
        Anaesthesiology. 1992; 77: 998-1006
        • Day TK
        • Muir III, WW
        α2-Adrenergic receptor agonist effects on supraventricular and ventricular automaticity in dogs with complete atrioventricular block.
        Am J Vet Res. 1993; 54: 136-141
        • Ebert TJ
        • Hall JE
        • Barney JA
        • et al.
        The effects of increasing plasma concentrations of dexmedetomidine in humans.
        Anaesthesiology. 2000; 93: 382-394
        • Ewing KK
        • Mohammed HO
        • Scarlett J
        • et al.
        Reduction of isoflurane anaesthetic requirement by medetomidine and its restoration by atipamezole in dogs.
        Am J Vet Res. 1993; 54: 294-299
        • Faber ESL
        • Chambers JP
        • Evans RH
        Depression of NMDA receptor mediated synaptic transmission by four α2 adrenoceptor agonists on the in vitro rat spinal cord preparation.
        Br J Pharmacol. 1998; 124: 507-512
        • Feigl E
        Coronary physiology.
        Physiol Rev. 1983; 63: 1-205
        • Fisher B
        • Zornow M
        • Yaksh H
        • et al.
        Antinociceptive properties of intrathecal dexmedetomidine in rats.
        Eur J Pharmacol. 1991; 192: 221-225
        • Flacke W
        • Flacke J
        • Blow K
        • et al.
        Effect of dexmedetomidine, an alpha 2 adrenergic agonist, in the isolated heart.
        J Cardiothorac Vasc Anesth. 1992; 6: 418-423
        • Flacke W
        • Flacke J
        • Bloor B
        • et al.
        Effects of dexmedetomidine on systemic and coronary haemodynamics in the anesthetized dog.
        J Cardiothorac Vasc Anesth. 1993; 7: 41-49
        • Fleetwood-Walker S
        • Mitchell R
        • Hope P
        • et al.
        An alpha 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones.
        Brain Res. 1985; 334: 243-254
        • Grimm K
        • Tranquilli W
        • Thurmon J
        • et al.
        Duration of nonresponse to noxious stimulation after intramuscular administration of butorphanol, medetomidine, or a butorphanol-medetomidine combination during isoflurane administration in dogs.
        Am J Vet Res. 2000; 61: 42-47
        • Guo T
        • Jiang J
        • Buttermann A
        • et al.
        Dexmedetomidine injection into the locus ceruleus produces antinociception.
        Anesthesiology. 1996; 84: 873-881
        • Hämäläinen M
        • Pertovaara A
        The antinociceptive action of an alpha-2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not due to activation of descending inhibition.
        Brain Res Bull. 1995; 37: 581-587
        • Hammond RA
        • England GCW
        The effect of medetomidine premedication upon propofol induction and infusion anaesthesia in the dog.
        JVAA. 1994; 21: 24-28
        • Hayashi Y
        • Sumikawa K
        • Maze M
        • et al.
        Dexmedetomidine prevents epinephrine induced arrhythmias through stimulation of central alpha-2 adrenoceptors in halothane anaesthetized dogs.
        Anaesthesiology. 1991; 75: 113-117
        • Hellebrekers L
        • Sap R
        Medetomidine as a premedicant for ketamine, propofol or fentanyl anaesthesia in dogs.
        Vet Rec. 1997; 140: 545-548
        • Hellebrekers L
        • van Herpen H
        • Hird JF
        • et al.
        Clinical efficacy and safety of propofol or ketamine anaesthesia in dogs premedicated with medetomidine.
        Vet Rec. 1998; 142: 631-634
        • Heusch G
        • Deussen A
        • Schipke J
        • et al.
        Alpha-1 and alpha-2 adrenoreceptor mediated vasoconstriction of large and small canine coronary arteries in vivo.
        J Cardiovasc Pharmacol. 1984; 6: 961-968
        • Heymann M
        • Payne B
        • Hoffman J
        • et al.
        Blood flow measurements with radionuclide-labelled microspheres.
        Prog Cardiovasc Dis. 1977; 20: 55-79
        • Hieble J
        • Ruffolo R
        Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoreceptors.
        Ann N Y Acad Sci. 1995; 763: 8-21
        • Housmans P
        Effects of dexmedetomidine on contractility, relaxation and intracellular calcium transients of isolated ventricular myocardium.
        Anaesthesiology. 1990; 73: 919-922
        • Kamibayashi T
        • Hayashi Y
        • Mammoto T
        • et al.
        Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.
        Anesthesiology. 1995; 83: 992-999
        • Kamibayashi T
        • Mammoto T
        • Hayashi Y
        • et al.
        Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs.
        Anesthesiology. 1995; 83: 1082-1089
        • Khan Z
        • Ferguson C
        • Jones R
        Alpha-2 and imidazoline receptor agonists.
        Anaesthesia. 1999; 54: 146-165
        • Ko J
        • Fox S
        • Mandsager R
        Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs.
        J Vet Med Assoc. 2000; 216: 1578-1583
        • Kuusela E
        • Raekallio M
        • Antilla M
        • et al.
        Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs.
        J Vet Pharmacol Ther. 2000; 23: 15-20
        • Kuusela E
        • Raekallio M
        • Vainio O
        • et al.
        Comparison of medetomidine and dexmedetomidine as premedicants in dogs undergoing propofol-isoflurane anaesthesia.
        Am J Vet Res. 2001; 62: 1073-1080
        • Kuusela E
        • Vainio O
        • Short CE
        • et al.
        A comparison of propofol infusion and propofol/isoflurane anaesthesia in dexmedetomidine premedicated dogs.
        J Vet Pharmacol Ther. 2003; 26: 199-204
        • Langer S
        Presynaptic regulation of the release of catecholamines.
        Pharmacol Rev. 1981; 32: 337-362
        • Lawrence C
        • Prinzen F
        • de Lange S
        The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand.
        Anesth Analg. 1996; 82: 544-550
        • Lawrence C
        • Prinzen F
        • de Lange S
        The effect of dexmedetomidine on nutrient organ blood flow.
        Anesth Analg. 1996; 83: 1160-1165
        • Lemke K
        • Tranquilli W
        • Thurmon J
        • et al.
        Haemodynamic effects of atropine and glycopyrrolate in xylazine-isoflurane-anaesthetized dogs.
        Vet Surg. 1992; 22: 163-169
        • Link R
        • Desai K
        • Hein L
        • et al.
        Cardiovascular regulation in mice lacking alpha(2)-adrenergic receptor subtypes b and c.
        Science. 1996; 273: 803-805
        • Lipscombe D
        • Kongsamt S
        • Tsien R
        Alpha adrenergic inhibition of sympathetic neurotranmsmitter release mediated by modulation of N-type calcium-channel gating.
        Nature. 1989; 340: 639-642
        • MacDonald E
        • Scheinin M
        Distribution and pharmacology of alpha 2 adrenoceptors in the central nervous system.
        J Physiol Pharmacol. 1995; 46: 241-258
        • MacDonald E
        • Scheinin M
        • Scheinin H
        • et al.
        Comparison of the behavioural and neurochemical effects of the two optical enantiomers of medetomidine, a selective alpha-2-adrenoceptor agonist.
        J Pharmacol Exp Ther. 1991; 259: 848-854
        • Maze M
        • Tranquilli W
        Alpha-2 adrenoceptor agonists: defining the role in clinical anaesthesia.
        Anesthesiology. 1991; 74: 581-605
        • McQuay H
        Pharmacological treatment of neuralgic and neuropathic pain.
        Cancer Surv. 1988; 7: 141-159
        • Muir W
        • Werner L
        • Hamlin R
        Effects of xylazine and acetylpromazine upon induced ventricular fibrillation in dogs anaesthetized with thiamylal and halothane.
        Am J Vet Res. 1975; 36: 1299-1303
        • Nathan N
        • Feigl E
        Adrenergic vasoconstriction lessens transmural steal during coronary hypoperfusion.
        Am J Physiol. 1986; 19: H645-H653
        • Ossipov M
        • Harris S
        • LLoyd P
        • et al.
        Antinociceptive interaction between opioids and medetomidine: systemic addivity and spinal synergy.
        Anaesthesiology. 1990; 73: 1227-1235
        • Paton W
        • Vizi E
        The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip.
        Br J Pharmacol. 1969; 35: 10-28
        • Pertovaara A
        Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies.
        Prog Neurobiol. 1993; 40: 691-709
        • Pertovaara A
        • Kauppila A
        • Tukeva T
        The effect of medetomidine, an alpha-2-adrenoceptor agonist, in various pain tests.
        Eur J Pharmacol. 1990; 179: 323-328
        • Pertovaara A
        • Hämäläinen M
        • Jyvasjarvi E
        • et al.
        Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in medetomidine-induced antinociception.
        Neuroscience. 1991; 44: 705-714
        • Pypendop B
        • Verstegen J
        A comparison of the sedative and analgesic effects of buprenorphine in combination with acepromazine, midazolam or medetomidine in dogs.
        Vet Anaesth Analg. 1994; 21: 15-20
        • Pypendop B
        • Verstegen J
        Haemodynamic effects of medetomidine in the dog: a dose titration study.
        Vet Surg. 1998; 27: 612-622
        • Pypendop B
        • Verstegen J
        Effects of a medetomidine-midazolam-butorphanol combination on renal cortical, intestinal and muscle microvascular blood flow in isoflurane anaesthetized dogs: a laser Doppler study.
        Vet Anaesth Analg. 2000; 27: 36-44
        • Roekaerts P
        • Prinzen F
        • de Lange S
        Coronary vascular effects of dexmedetomidine during reactive hyperemia in the anaesthetized dog.
        J Cardiothorac Vasc Anesth. 1996; 10: 619-626
        • Roekaerts P
        • Prinzen F
        • de Lange D
        Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs.
        Br J Anaesth. 1996; 77: 427-429
        • Salonen J
        Chemistry and pharmacokinetics of the alpha2-adrenoceptor agonist.
        in: Short C Poznack AV Animal Pain. Churchill Livingstone, New York1992
        • Savola J
        Cardiovascular actions of medetomidine and their reversal by atipamezole.
        Acta Anaesthesiol Scand. 1989; 85: 39-47
        • Scheinin M
        • Schwinn D
        The locus coeruleus: site of hypnotic actions of alpha2-adrenoreceptor agonists?.
        Anaesthesiology. 1992; 76: 873-875
        • Schmeling W
        • Kampine J
        • Roerig D
        • et al.
        The effects of the stereoisomers of the alpha2 adrenegic agonist medetomidine on systemic and coronary haemodynamics in conscious dogs.
        Anaesthesiology. 1991; 75: 499-511
        • Seiten E
        • Flacke W
        • Alper M
        Effects of calcium on isolated mammalian hearts.
        Am J Physiol. 1964; 207: 716-720
        • Sullivan A
        • Kalso E
        • McQuay H
        • et al.
        The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat.
        Eur J Pharmacol. 1992; 215: 127-133
        • Thurmon J
        • Ko J
        • Benson G
        • et al.
        Hemodynamic and analgesic effects of propofol infusion in medetomidine-premedicated dogs.
        Am J Vet Res. 1994; 55: 363-367
        • Tibirica E
        • Feldman J
        • Mermet C
        • et al.
        An imidazoline specific mechanism for the hypotensive effect of clonidine. A study with yohimbine and idazoxan.
        J Pharmacol Exp Ther. 1991; 256: 606-613
        • Tranquilli W
        • Thurman J
        • Benson G
        Alterations in epinephrine-induced arrhythmogenesis after xylazine and subsequent yohombine administration in isoflurane anaesthetized dogs.
        Am J Vet Res. 1988; 49: 1072-1075
        • Uhlén S
        • Wikberg J
        Rat spinal cord alpha-2-adrenoceptors are of the alpha-2A-subtype: comparison with alpha-2A- and alpha-2B-adrenoceptors in rat spleen, cerebral coretx and kidney using 3H-RX821002 ligand binding.
        Pharmacol Toxicol. 1991; 69: 341-350
        • Unnerstall J
        • Kopajtic T
        • Kuhar M
        Distribution of alpha-2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomical correlates of the pharmacological effects of clonidine and related adrenergic agents.
        Brain Res Brain Res Rev. 1984; 7: 69-101
        • Vainio O
        • Ojala M
        Medetomidine, an alpha2 agonist, alleviates post thoracotomy pain in dogs.
        Lab Anim. 1994; 28: 369-375
        • Verstegen J
        • Fargetton X
        • Donnay I
        • et al.
        Comaprison of the clinical utility of medetomidine/ketamine and xylazine/ketamine combinations for ovariectomy of cats.
        Vet Rec. 1990; 127: 424-426
        • Vickery R
        • Sheridan B
        • Segal I
        • et al.
        Anesthetic and haemodynamic effects of the stereoisomers of medetomidine, an alpha 2 adrenergic agonist, in halothane anesthetized dogs.
        Anesth Analg. 1988; 67: 611-615
        • Wei H
        • Pertovaara A
        Peripherally administered alpha 2 adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
        Anesth Analg. 1997; 85: 1122-1127
        • Wikberg J
        Synthesis of 3H-acetylcholine in the rabbit lacrimal gland and its release by electrical field stimulation.
        Acta Physiol Scand. 1979; 468: 1-89
        • Williams JT
        • Henderson G
        • North RA
        Characterization of alpha 2-adrenoreceptors which increase potassium conductance in rat locus coeruleus neurones.
        Neuroscience. 1985; 14: 95-101
        • Woodman O
        • Vatner S
        Cardiovascular responses to the stimulation of alpha 1 and alpha 2 -adrenoreceptors in the conscious dog.
        J Pharmacol Exp Ther. 1986; 237: 86-91
        • Xu M
        • Wei H
        • Kontinen K
        • et al.
        The dissociation of sedative from spinal antinociceptive effects following adminsitration of a novel alpha-2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat.
        Acta Anaesthesiol Scand. 2000; 44: 648-655
        • Yaksh T
        Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing.
        Pharmacol Biochem Behav. 1985; 22: 845-858
        • Yaksh T
        • Pogrel J
        • Lee YW
        • et al.
        Reversal of nerve-ligation induced allodynia by spinal alpha 2 adrenoceptor agonists.
        J Pharmacol Exp Ther. 1995; 272: 207-214
        • Young L
        • Brearley J
        • Richards D
        • et al.
        Medetomidine as a premedicant in dogs and its reversal by atipamezole.
        J Small Anim Pract. 1990; 31: 554-559
        • Zanderberg P
        • Timmermans P
        • Zwieten PV
        Hemodynamic profiles of methohexamine and B-HT 933 in spinalized ganglion blocked dogs.
        J Cardiovasc Pharmacol. 1984; 6: 256-262